BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15497761)

  • 1. Compatibility of sennoside A and B with pharmaceutical excipients.
    Verloop Q; Marais AF; de Villiers MM; Liebenberg W
    Pharmazie; 2004 Sep; 59(9):728-30. PubMed ID: 15497761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing.
    Verma RK; Garg S
    J Pharm Biomed Anal; 2005 Jul; 38(4):633-44. PubMed ID: 15967291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets.
    Monajjemzadeh F; Hassanzadeh D; Valizadeh H; Siahi-Shadbad MR; Mojarrad JS; Robertson TA; Roberts MS
    Eur J Pharm Biopharm; 2009 Nov; 73(3):404-13. PubMed ID: 19631740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of HPLC to assess the compatibility of bisoprolol fumarate with selected excipients in mixtures by isothermal stress testing.
    Marothu VK; Yerramothu P; Gorrepati M; Majeti S; Mamidala SK; Nellutla A
    Ann Pharm Fr; 2015 Nov; 73(6):442-51. PubMed ID: 26142745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility studies between carbamazepine and tablet excipients using thermal and non-thermal methods.
    Joshi BV; Patil VB; Pokharkar VB
    Drug Dev Ind Pharm; 2002 Jul; 28(6):687-94. PubMed ID: 12149961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.
    Thumma S; Repka MA
    Pharmazie; 2009 Mar; 64(3):183-9. PubMed ID: 19348341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy.
    Mura P; Faucci MT; Manderioli A; Bramanti G; Ceccarelli L
    J Pharm Biomed Anal; 1998 Oct; 18(1-2):151-63. PubMed ID: 9863953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-excipient incompatibility studies of the dipeptide angiotensin-converting enzyme inhibitor, moexipril hydrochloride: dry powder vs wet granulation.
    Gu L; Strickley RG; Chi LH; Chowhan ZT
    Pharm Res; 1990 Apr; 7(4):379-83. PubMed ID: 2362911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential scanning calorimetry to investigate the compatibility of ciprofloxacin hydrochloride with excipients.
    Fathy M; Hassan MA; Mohamed FA
    Pharmazie; 2002 Dec; 57(12):825-8. PubMed ID: 12561245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
    Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
    J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on compatibility assessment of empagliflozin with the selected pharmaceutical excipients employed in solid dosage forms by thermal, spectroscopic and chromatographic techniques.
    Niguram P; Polaka SN; Rathod R; Kalia K; Kate AS
    Drug Dev Ind Pharm; 2020 Feb; 46(2):209-218. PubMed ID: 31933394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple and rapid analysis of sennoside A and sennoside B contained in crude drugs and crude drug products by solid-phase extraction and high-performance liquid chromatography.
    Yamasaki K; Kawaguchi M; Tagami T; Sawabe Y; Takatori S
    J Nat Med; 2010 Apr; 64(2):126-32. PubMed ID: 20091132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-excipient compatibility studies in binary mixtures of avobenzone.
    Ceresole R; Han YK; Rosasco MA; Orelli LR; Segall A
    J Cosmet Sci; 2013; 64(5):317-28. PubMed ID: 24139431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state compatibility studies using a high-throughput and automated forced degradation system.
    Wakasawa T; Sano K; Hirakura Y; Toyo'oka T; Kitamura S
    Int J Pharm; 2008 May; 355(1-2):164-73. PubMed ID: 18215480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An HPLC method to determine sennoside A and sennoside B in Sennae fructus and Sennae folium.
    Rosenthal I; Wolfram E; Meier B
    Pharmeur Bio Sci Notes; 2014; 2014():92-102. PubMed ID: 25655246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal and non-thermal methods to evaluate compatibility of granisetron hydrochloride with tablet excipients.
    Late SG; Banga AK
    Pharmazie; 2008 Jun; 63(6):453-8. PubMed ID: 18604989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal analysis as a screening technique in preformulation studies of picotamide solid dosage forms.
    Mura P; Faucci MT; Manderioli A; Furlanetto S; Pinzauti S
    Drug Dev Ind Pharm; 1998 Aug; 24(8):747-56. PubMed ID: 9876522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of components in drug formulations: a comparison between HPLC and DSC methods.
    Ceschel GC; Badiello R; Ronchi C; Maffei P
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):1067-72. PubMed ID: 12899995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.